1. Ion Channels in Gliomas—From Molecular Basis to Treatment
   Abdallah F. Elias et al, 2023, International Journal of Molecular Sciences CrossRef
2. Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation
   Fengchao Xu et al, 2022, Virus Research CrossRef
3. The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells
   Stefanie Binder et al, 2021, Scientific Reports CrossRef
4. Inhibition of TRPM7 with carvacrol suppresses glioblastoma functions in vivo
   Rahmah Alanazi et al, 2022, European Journal of Neuroscience CrossRef
5. Salvianolic acid A (Sal A) suppresses malignant progression of glioma and enhances temozolomide (TMZ) sensitivity via repressing transgelin-2 (TAGLN2) mediated phosphatidylinositol-3-kinase (PI3K) / protein kinase B (Akt) pathway
   Tingting Ye et al, 2022, Bioengineered CrossRef
6. TRIM family contribute to tumorigenesis, cancer development, and drug resistance
   Ning Huang et al, 2022, Experimental Hematology & Oncology CrossRef
7. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
   Mehrdad Hashemi et al, 2023, Biomedicine & Pharmacotherapy CrossRef
8. TRIM31: A molecule with a dual role in cancer
   Yafei Guo et al, 2022, Frontiers in Oncology CrossRef
9. Choline Kinase Alpha Promoted Glioma Development by Activating PI3K/AKT Signaling Pathway
   Yourui Zou et al, 2021, Cancer Biotherapy and Radiopharmaceuticals CrossRef
10. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt/β-catenin pathway by regulating Axin1 protein stability
    Qi Feng et al, 2023, Scientific Reports CrossRef
11. Emerging Roles of TRIM Family Proteins in Gliomas Pathogenesis
    Angeliki-Ioanna Giannopoulou et al, 2022, Cancers CrossRef